Collection, monitoring and evaluation of safety data is a key responsibility of the Sponsor and Investigator and the first goal listed by the FDA. Adverse events and serious adverse events are key data elements to review the safety of a product. An adverse event is defined as an untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product that does not necessarily have a causal relationship with this treatment. This course will introduce you to common safety monitoring practices and the regulatory reporting responsibilities for medical products.
|Dates||Days and Times||Location||Faculty|
|3/6/19-3/27/19||Wed, 6:00PM-7:30PM||Online||Bethany Van Veen|
* Course Fee: $310
* For access to online class, visit https://ilearn.sfsu.edu
|Refund Code||Full Refund||75% Refund||No Refund|
|CEL_1||Class dropped one day prior to class start day||N/A||Class dropped on or beyond class start day|
Last Update: Dec 11, 2018 1:51pm